Activation of phospholipase C (PLC) increases in tracellular Ca++ and may play a role in delayed neuronal death after ischemia. Because changes in intracellular Ca++ are be lieved to participate in ischemic neuronal injury, we tested the hypothesis that PLCI3 protein levels are temporally altered in brain regions that undergo neurodegeneration after global in complete ischemia. Dogs (n = 12) were subjected to 20 min utes of global incomplete ischemia followed by recovery of either 1 (n = 5) or 7 days (n = 7). Six sham-operated animals were used as nomschemic controls. In hematoxylin and eosin stained brain sections, neuronal density at I day after ischemia was unchanged relative to nonischemic controls in hippocam pus CAl, caudate, and cerebellar cortex (anterior lobule). How ever, at 7 days after ischemia, neuronal densities were de creased to 56 ± 15% (mean ± SO) and 75 ± 17% of control in CAl and caudate, respectively. At I and 7 days after ischemia, Abbreviations used: ICP, intracranial pressure; mGluR, metabo tropic glutamate receptors; OD, optical density units; PLC. phospholi pase C. J Cell Bioi 113:1145-1157 Wieloch T, Bergstedt K, Hu BR (1993) Protein phosphorlyation and the regulation of mRNA translation following cerebral ischemia. Prog Brain Res 96:179-191
the percentage of neurons showing ischemic injury increased from 13 ± 10 to 40 ± 35% in CA l, 24 ± 25 to 59 ± 16% in cerebellum, and 4 ± 2 to 18 ± 12% in caudate. Densitometric analysis of immunocytochemically stained brain sections from controls (n = 3), 1 day after ischemia (n = 3), and 7 days after Phospholipase C (PLC) is a ubiquitous family of iso enzymes within the brain. Expression of brain PLC var ies on a regional and cellular basis (Gerfen et ai., 1988; Mizuguchi et ai., 1991) . Phospholipase C activation is ischemia (n = 5) revealed that PLCI3 immunoreactivity was increased in cerebellum at I day (0.274 ± 0.013 v 0.295 ± 0.005 optical density units [00] in control and I day, respec tively) and 7 days (0.\08 ± 0.009 v 0.116 ± 0.005 0.0. in control and 7 days, respectively). PLCI3 immunoreactivity was unchanged after ischemia in caudate and hippocampus. West ern blot analysis of PLCI3 immunoreactivity in the cerebellar cortex and hippocampus in the control (n = 3), I day (n = 2), and 7 days after ischemia (n = 2) groups showed that PLCI3 levels were increased after ischemia in cerebellum 266% and 227% above control at 1 and 7 days, respectively, However, in hippocampus, PLC expression after ischemia was unchanged at 97% and 84% of control at I and 7 days, respectively. These results show that delayed neuronal degeneration after global incomplete ischemia is accompanied by regional abnormalities in PLC levels. Elevated PLC levels early may represent an aberrant signal transduction mechanism resulting in delayed cell damage, whereas decreased PLC levels later after ischemia may reflect ongoing neurodegeneration. Key Words: Ischemic neurodegeneration-CA I-Signal Transduction-Intracellular Ca++ homeostasis.
part of an intricate, neuronal intracellular signal trans duction cascade and occurs via receptor activation coupled to a G protein. Ischemia modifies the processes involved in receptor activation (Wieloch et ai., 1993) . For example, changes in PLC activity and expression alter membrane integrity and intracellular Ca++ regula tion, and changes in PLC activity can negatively influ ence the interactions among N-methyl-o-aspartate and metabotropic glutamate receptors after ischemia. Thus, PLC may play a role in receptor-mediated neuronal death after ischemia.
Therefore, we sought to determine if PLC expression is altered after brain ischemia. We tested the hypothesis that expression of PLCI3 is altered on a temporal and regional basis after global incomplete ischemia in dogs.
METHODS

Temporary global incomplete ischemia
Dogs (n = 12) were anesthetized with halothane (1 to 2% inspired). The trachea was intubated and the lungs were me chanically ventilated. A peripheral intravenous catheter was placed and pancuronium bromide (0.1 mg/kg, intravenously) was injected for muscle paralysis. A femoral artery was can nulated for blood pressure measurement and blood sampling. The left temporalis muscle over the lambdoidal suture was retracted from the skull. After placing a small burr hole, a thermistor was inserted between bone and dura to monitor epi dural temperature. A second small burr hole was placed and a Silastic ventricular drain catheter with multiple side ports was inserted into the lateral ventricle for measuring intracranial pressure (ICP) and infusing artificial cerebrospinal fluid (Hum et a!., 1991; Sieber et a!., 1994; Palmon et a!., 1995) . Arterial line placement, intraventricular catheter placement, and pro duction of ischemia were all performed using strict sterile pre cautions. The body of the dog was wrapped in a plastic bag and placed on a blanket perfused with recirculating warm water. Heat lamps were used, if necessary, to maintain epidural tem perature at 37 to 38°C. End-tidal CO2 was monitored and ven tilation adjusted to maintain Paeo2 35 to 40 mm Hg. Mean arterial pressure and ICP were continuously recorded. Inspired O2 was = 30% to maintain oxyhemoglobin saturation. Supple mental oxygen was administered until approximately 30 min utes after ischemia (when the animal was extubated).
Incomplete ischemia was produced in dogs (n = 12) by infusing sterile artificial cerebrospinal fluid into the lateral ven tricle to proq.uce an ICP 10 mm Hg below the animal's mean arterial blood pressure. The artificial cerebrospinal fluid was prewarmed and maintained at a temperature of 38°C. Six dogs served as sham-operated nonischemic controls. A moderate pressor response resulted, but ICP was easily manipulated to help keep cerebral perfusion pressure constant at 10 mm Hg for 20 minutes. Cerebral blood t10w during ischemia ranged from 2 to 11 mL/min/lOO g (Sieber et a!., 1994) . This was sufficient to reduce cerebral O2 uptake, flatten the somatosensory evoked potentials, and reduce phosphocreatine and ATP levels (Sieber et a!., 1994; Palmon et a!., 1995) . To start reperfusion, the cerebrospinal fluid pressure reservoir was disconnected and ICP allowed to normalize.
Arterial blood pressure and ICP were measured continuously with Statham pressure transducers (Quest Medical, Allen, TX, U.S.A.). Arterial Po2, Peo2, and pH were measured with Ra diometer BMS3 electrodes and analyzer (Radiometer, Nevada, Denmark). Arterial oxygen content, saturation, and hemoglobin concentration were determined with a Hemoximeter3 (Radiom eter). Arterial glucose concentration was measured with a Yel low Springs Glucose/Lactate analyzer (Yellow Springs, Yellow Springs, OH, U.S.A.). All analyzers were calibrated routinely throughout each experiment as performed in our previous work (Hum et a!., 1991) . After the ischemic episode, all catheters were removed, bleeding controlled, and skin incisions sutured before awakening the animal from anesthesia.
Conventional neuropathology
For conventional neuropathologic and immunocytochemical analysis, nonischemic controls and ischemic animals were anesthetized with pentobarbital, anticoagulated with heparin, and their brains perfused with phosphate-buffered saline fol lowed by 4% paraformaldehyde. After removal, each brain was divided midsagittally and the hemispheres were cut systemati cally into I cm-thick coronal slabs from anterior to posterior. From the left hemisphere, the midhippocampus and surround-J Cereb Blood Flow Metab, Vol. 17, No.5, 1997 ing temporal neocortex, frontal cortex, caudate (head), and cer ebellum were sampled consistently for paraffin histology and hematoxylin and eosin (H&E) staining. In this model of isch emia, neuronal damage is similar bilaterally . The right cerebrum and cerebellum was systematically cut into 1 cm-thick coronal slabs, cryoprotected in 20% buff ered-glycerol, frozen in isopentane, and stored at -80°C for immunocytochemical analyses. Cerebellar and cerebral samples were cut serially into 40-micron sections and trans ferred into antifreeze buffer for storage until used for immu nocytochemistry. Sections of three brain regions were stained with hematoxylin and eosin and evaluated quantitatively for ischemic injury: the hippocampus (CAl), the caudate nucleus, and the anterior cerebellar lobule at the midline. We selected these areas because in other models of ischemia these regions are damaged. In addition, these regions can be sampled and examined consistently. Purkinje cells in the cerebellum were counted in 4 fields at 200x magnification in the rostral cerebel lar folia (anterior/rostral vermis) against the pons and above the fourth ventricle. The left hippocampal CA 1 region was counted at the midhippocampal level in 6 fields at 600x magnification.
The caudate was examined in 5 fields at 1000x magnification.
In sections stained with hematoxylin and eosin, the number of neurons were counted and the percent of neurons with ischemic damage was determined using the criterion of microvacuolar change within the cell body, peripheralization of chromatin, perinuclear eosinophilia, or perikaryal shrinkage with eosino philic cytoplasm. Ischemic neuronal damage was determined by a blinded investigator (LM) who evaluated the three regions of interest separately. The percent of neuronal damage in each region was averaged for each animal and a group mean calcu lated. The number of neurons/mm 2 was calculated for each region in both the ischemic and nonischemic animals and the percent of neurons remaining calculated for the ischemic ani mals.
Immunocytochemistry
We examined changes in the PLCr31 isoform. Although PLC has several isoforms in brain and especially neurons, the pre dominant isoform is PLCr3 . Immunocyto chemistry was performed in hippocampus, striatum, and cer ebellum sections using standard immunoperoxidase procedures Martin et a!., 1992) to localize PLC r31 (Santa Cruz Biotechnology, Santa Cruz, CA, U.S.A.). Sections of brain from each experimental group were processed concurrently using the same batches of reagents to obviate tissue section variability in antigen localization. These preparations were analyzed using a computer-based image analysis system to determine regional optical density of immu noreactivity (Martin et a!., 1991) .
Selected sections were incubated with PLCr31 preabsorbed against a synthetic PLCr31 antigen (Santa Cruz Biotechnology).
Quantitative immunoblot analysis
Control and ischemic animals were exsanguinated by intra aortic perfusion of phosphate-buffered saline; and the brains were quickly removed. The right cerebrum and cerebellum were frozen unfixed for homogenization; the left hemisphere was cut into l-cm slabs and fixed by immersion in 5% acrolein prepared in phosphate buffer for paraffin histology. The brains of these animals were prepared in this manner because of the necessity to use fresh tissue for western blotting. However, we also wanted to assess the severity of ischemic damage in these animals. Fresh-frozen brain samples of cerebellar cortex were homogenized and protein assays were conducted as described previously Martin et a!., 1992) . For western blotting, P2 fractions (10 f-lg protein) were subjected to SDS-PAGE, electroblotted onto nitrocellu lose membrane, and probed with affinity-purified polyclonal antibodies to PLCI3 (Martin et aI., 1993; Martin et aI., 1993; Martin et aI., 1992; Fotuhi et aI., 1993) . We focused on the membrane fraction because this is the fraction of primary PLCI3 enrichment. The same blots that were probed for PLCI3 were probed with a monoclonal antibody to synaptophysin (Boehringer Mannheim, Indianapolis, IN) to establish that comparable amounts of protein were loaded in each lane. Syn aptophysin (p38) was selected because presynaptic proteins are generally preserved after cerebral ischemia (Kitagawa et aI., 1992) . Immunoblots were quantified densitometrically to evaluate regional brain changes in the levels of PLCI3 in post ischemic animals relative to controls. Films were scanned using Adobe Photoshop software (Adobe Systems, Buffalo, NY, U.S.A.) for Macintosh (Apple Computer, Inc., Cupertino, CA) and an Agfa Arcus Plus scanner (Agfa Division, Bayer Corp, Ridgefield, NJ, U.S.A.). Densitometric analysis was perfonned using Signal Analytics IP Lab Gel software (Signal Analytics, Vienna, VA, U.S.A.). PLC131 and synaptophysin protein levels were expressed as relative optical density (OD) measurements, determined by comparing the density and area of the immuno reactive band in each lane scanned to control lanes in the same blot. PLC131 levels were nonnalized to synaptophysin measure ments to control for errors in loading. The relative values for each animal were replicated in duplicate immunoblotting ex periments.
Experimental design
In postischemic and sham animals, we quantitatively and qualitatively evaluated, in cerebellar cortex, hippocampus, and caudate, protein hpression of PLCI3 by immunocytochemistry and western blotting. We used our model of 20 minutes of global incomplete ischemia to detennine protein expression at 3 time points: control nonischemic sham-operated dogs, 1 day after ischemia, and 7 days after ischemia.
The nonischemic, sham-operated animals were anesthetized, underwent similar surgical procedures as their ischemic coun terparts, and then were killed (n = 6 total; n = 3 for immu nocytochemistry and n = 3 for western blotting). To obtain the 1 day (n = 5 total; n = 3 for immunocytochemistry and n = 2 for western blotting) and 7 day (n = 7 total; n = 5 for immunocytochemistry and n = 2 for western blotting) recov ery measurements, animals were anesthetized, followed by sterile placement of mean arterial pressure and ICP catheters. Twenty minutes of global incomplete ischemia was produced, the animal was allowed to recover I or 7 days, then was killed. Neuropathologic scores between groups and regions at each time point were analyzed using the Mann-Whitney test. Quan titation of protein expression by immunocytochemistry was analyzed on a regional and temporal basis using T -Test.
RESULTS
Twelve dogs underwent 20 minutes of global incom plete ischemia. Arterial blood gas values immediately before ischemia were pH = 7.39 ± 0.05, Pco2 = 32 ± 4, an d P02 = 282 ± 155. Preischemic blood glucose level was 5.3 ± 2.1 mmol/L and hemoglobin was 13.1 ± 2.6 g/dL. Epidural temperature during ischemia was 37.9 ± O.6°C. No ischemic animals were eliminated from the stu d y and all dogs survived for their respective postisch emic time periods.
Delayed neuronal damage after incomplete global ischemia In the cerebellum, hippocampus, and caudate, the per cent of neurons damaged at 24 hours was less than the percent of neurons damaged at 7 days after ischemia. In addition, in all three regions there was minimal neuronal dropout at 24 hours after ischemia. Damage in cerebel lum and CAl was greater than in caudate (Fig. 1) .
In the cerebellum, the percentage of damaged Purkinje cells increased from 24% to 59% at 1 and 7 days, re spectively. Purkinje cell damage occurred evenly in both the crown and sulci. There was minimal Purkinje cell dropout throughout the postischemic time period.
CAl pyramidal cell damage increased from 13% to 40% of remaining neurons damaged at I and 7 days after ischemia. At 7 days after ischemia, approximately 56% of pyramidal cells remained. The pattern of CA I damage increased on moving from the subiculum to CA2. Pri marily, the neurons in the superficial layers of CA l showed evidence of ischemic cell change at 1 day after ischemia. This pattern progressed by 7 days to include primarily the pyramidal cell layer.
The caudate was less damaged than the cerebellum and hippocampus. At 24 hours, ischemic cell change was observed in 4% of neurons which increased to 18% dam-age of the remaining neurons by 7 days. Damage was uniform throughout the region. By 7 days after ischemia, 75% of neurons remained in the caudate.
Time-dependent changes in PLCfn protein expression after ischemia
In nonischemic controls, PLC immunoreactivity was enriched in Purkinje cell bodies and their proximal den dritic processes (Fig. 2) , with the molecular layer stain ing more intensely for PLCj3 than the granule cell layer (0.547 ± 0.054 v 0.285 ± 0.015 optical units, respec tively). Densitometric analysis of immunocytochemi cally stained brain sections from controls (n = 3), I day (n = 3), and 7 days after ischemia (n = 5) revealed that PLC� immunoreactivity was increased in cerebellum at 1 day (0.274 ± 0.013 v 0.295 ± 0.005 OD in control and 1 day, respectively) and 7 days (0.108 ± 0.009 v 0.116 ± 0.005 OD in control and 7 days, respectively). After ischemia, PLC expression in the molecular layer in creased in intensity at 1 day, and remained increased at 7 days after ischemia (0.547 ± 0.094 v 0.570 ± 0.064 OD in control and 7 day after ischemia, respectively). In particular, the arborization of the Purkinje cell dendrites was clearly visualized at 1 and 7 days after ischemia (Fig. 2) . Staining of the granule cell layer decreased in intensity by 7 days after ischemia (0.285 ± 0.015 v 0.278 ± 0.015 OD in control and 7 day after ischemia, respec tively).
In the nonischemic controls, the pyramidal cell bodies and their proximal dendrites in the CA 1 hippocampal region were heavily immunoreactive. PLC� immunore activity was unchanged in hippocampus at 1 day (0.358 ± 0.015 v 0.370 ± 0.019 OD in control and 1 day, re spectively) and 7 days after ischemia (0.326 ± 0.019 v 0.324 ± 0.024 OD in control and 7 days, respectively). At 1 day after ischemia, the stratum radiatum became heav ily immunoreactive and a modest increase in CA 1 im munoreactivity occurred. Yet at 7 days, the neuropil was only modestly immunoreactive (Fig. 2) . This loss of im munostaininglWas related to the degree of neuronal drop out and resulted in no change in CAl immunoreactivity by 7 days after ischemia (0.136 ± 0.009 v 0.134 ± 0.015 OD in control and 7 days, respectively).
As reported previously (Fotuhi et aI., 1993) , in non ischemic controls, immunostaining for PLC� in the stria tum occurred predominately in the medium-sized neuro nal perikarya and neuropil. At 1 day after ischemia, the principal neurons and neuropil showed enhanced PLC� immunoreactivity relative to controls. By 7 days, there was still a comparable amount of neuronal cell body immunoreactivity, but decreases had occurred in the neu ropil, especially in the putamen. There was no difference in immunoreactivity in the caudate postischemically by densitometry (0.144 ± 0.017 v 0.136 ± 0.026 OD in control and 7 days, respectively).
To determine whether initial increases in PLC�l ex pression observed in CA I and cerebellum represent a generalized response to ischemia or are specific for se lectively vulnerable regions, we performed densitometric analysis on brainstem and thalamic immunocytochemi cal PLCpreparations at 1 day and 7 days after ischemia. These regloJls\Vere chosen because our initial histologic and physiologic studies of the current model of incom plete ischemia show that significant decreases in regional blood flow occur in these regions during ischemia (Sieber et aI., 1994) ; however, neuronal damage is mini mal at 7 days (Sieber et aI., 1995) . Immunocytochemical optical densities showed no change in PLC�l expression from control at 1 day and 7 days after ischemia in both the thalamus and the brainstem.
All immunoreactivity in dog brain sections was com pleted by addition of the antigen with which the PLC�l antibody was made.
By western blotting, PLC�l expression significantly increased in cerebellum to 266% and 227% of control at 1 and 7 days after ischemia, respectively. In the whole hippocampus, PLC� 1 expression was 97% control and 84 % control at I and 7 days after ischemia (Fig. 3) .
DISCUSSION
These results show that sustained postischemic in creases in PLC� 1 protein expression occur on a regional and cellular basis. Specifically, in cerebellum, Purkinje cell and molecular layers show enhanced PLC levels postischemically. Although in the hippocampus, CAl pyramidal cells express PLC, postischemic increases were not evident at 7 days recovery. Immunocytochem istry revealed that PLC increases occur in the somato dendritic compartment concurrently with neuronal drop out in the hippocampus. Delayed postischemic decreases in regional PLC� expression probably occur as a result of ultimate degeneration of dendrites. These results are consistent with the loss of cytoskeletal markers for den drites and spines (e.g., microtubule-associated protein-2 immunoreactivity) postischemically (Matesic, Rick, 1994) , and further suggest that postsynaptic perturba tions in dendrites may be an early sign of postischemic delayed neuronal death.
PLC� levels are high in the caudate and CAl (Gerfen et aI., 1988) , accounting for greater than 50% of total
Western blot analysis of PLCi3, and synaptophysin (p38) levels in cerebellar cortex and hippocampus. PLCi3, and synap tophysin levels in cerebellar cortex are demonstrated in rows A and B, respectively. PLCi3, and synaptophysin levels in hippo campus are demonstrated in rows C and 0, respectively. Lanes 1, 2, and 3 are nonischemic controls. Lanes 4 and 5 are animals killed 1 day after ischemia. Lanes 6 and 7 are animals killed 7 days after ischemia.
PLC activity in rat brain (Takenawa et aI., 1991) . Immu noblotting studies show that the relative level of PLC� expression in cell culture is greatest in neurons, then oligodendrocytes, and least in astrocytes (Mizuguchi et aI., 1991) . The current study has not documented the responses of PLC isoforms other than PLC� l' Thus, we cannot determine from our data whether the early post ischemic increases in PLC� protein levels are a compen satory response to decreases in other PLC isoforms. In addition, our. experiments have not shown whether the early postischemic increase in PLC protein expression is accompanied by a gain in PLC function, ,or whether in creased PLC protein levels reflect a loss of biochemical function of PLC. However, previous investigations sug gest that PLC activity is not altered by brain ischemia (Nishida et aI., 1994) .
It is possible that increases in PLC� may represent compensatory responses to postischemic decreases in cellular inositol triphosphate (IP3) binding (Kato et aI., 1992; Kato et aI., 1991) . Marked alterations in intracel lular signal transduction take place early, within 3 hours, after ischemic insult, and precede delayed neuronal death (Onodera and Kogure, 1989) . The IP3 cascade has at least been implicated in the induction of neurodegenera tion. Deceases in IP3 cellular binding may reflect pri mary damag � to IP3 receptors in subcellular compart ments or downregulation of this receptor (Walton et aI., 1991) . In addition, stimulation of inositol phospholipid hydrolysis by glutamate and norepinephrine increases by 24 hours after ischemia; an effect that lasts for at least 1 week (Seren et aI., 1989 ). An increase in metabotropic glutamate receptors (mGluR) that function via G proteins coupled to PLC (i.e., mGluRI and mGluR5) may be a mechanism for the PLC changes. Our study extends these previous findings by showing that a sustained in crease in PLC expression occurs postischemically. How ever, it remains to be ascertained whether mGluR is re sponsible for this effect and the relative contributions of adrenergic versus mGluR stimulation in producing these changes. Future studies examining the changes in expres sion or activity of the G q class of G proteins, specific for PLC� are needed to answer this question (Rhee, Choi, 1992; Taylor et aI., 1991) .
A common sequelae of ischemia-producing infarction is gliomesodermal scarring with angiogenesis that occurs in the damaged areas. Capillaries contain many different receptors that couple to PLC resulting in enriched ex pression of the enzyme. However, the current model of ischemia has little, if any, mesodermal scarring compo nent, and produces no infarction at 7 days recovery (Sieber et aI., 1995) . Thus, as confirmed by the cellular expression of the immunocytochemical preparations, it is unlikely that the documented PLC changes represent augmented vascular expression of the enzyme.
Phospholipase C may provide a mechanism for de-J Cereb Blood Flow Metab, Vol. 17, No.5, 1997 layed neuronal damage. Elevated intracellular Ca++ is a consistent feature of excitotoxic cell damage. Phospho lipase C is coupled to mGluR as well as other receptors which act through second messengers to produce post ischemic changes in intracellular Ca++. The lack of change in PLC expression in the thalamus and brainstem suggests that regional PLC increases are not a general ized response to ischemia, but rather are associated with ischemic neuronal damage in selectively vulnerable re gions. In support of this conclusion, several investigators have shown that PLC inhibition decreases the amount of neuronal dropout in CAl after ischemia in the rat (Ume mura et aI., 1992). In addition, pretraumatic PLC inhibi tion significantly improves neurologic outcome after traumatic brain injury in rats (Golding and Vink, 1994) .
In summary, this study shows that sustained increases in PLC expression occur up to 7 days after ischemia. These increases occur on a regional and cellular basis. It is unclear what cellular mechanisms are involved in pro moting these regional changes. However, PLC� in creases are occurring in the somatodendritic compart ment of neurons. In addition, regional PLC increases are not merely a generalized response to ischemia, but are associated with regional ischemic neuronal damage. These data show that increases in PLC expression are associated with delayed neuronal death after incomplete global ischemia.
